TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

Uniform recall procedure for therapeutic goods (URPTG), 2004 edition

2004 edition

Book pagination

12 April 2017

B. Stages of recall procedure

Recall stage See section
1

Notification to the Co-ordinator Crisis management

This should be to the Australian Recall Co-ordinator.

C
2

Information Required to Assess Recall

Information on product, problem and distribution is required, (see also - The Medicine Problem Report Form, Medical Device Incident Report Form and Human Blood and Tissues Report Form at Appendices I, II and III).

E
3

Assessment of Recall

Liaison between sponsor and Australian Recall Co-ordinator to assess classification, level and strategy of recall.

F
4

Recall

Letters and advertisements are submitted by the sponsor to the Australian Recall Co-ordinator for approval before despatch.

G
5

Notification to the Federal Minister Responsible for Consumer Affairs

Where the recall is safety-related, there is a legal requirement to notify the Minister via the Product Safety Policy Unit, Australian Competition and Consumer Commission (ACCC).

M
6

Progress of Recall and Report

Progress reports are forwarded to the Australian Recall Co-ordinator.

H
7

Follow-up Action

The effectiveness of the recall is monitored by the Australian Recall Co-ordinator.

K

Book pagination